Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ondansetron QTc effects in pediatric chemotherapy
NCT01896440Phase 4Withdrawn
- Sponsor
- University of Oklahoma
- Start
- Oct 2013
- Primary completion
- Oct 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of ondansetron in chemotherapy-induced nausea and vomiting (CINV), sponsored by University of Oklahoma. Planned start Oct 2013; status: withdrawn.
02
Drugs
ondansetron
03
Conditions
chemotherapy-induced nausea and vomiting (CINV)
Beyond the preview
Go deeper on NCT01896440.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01896440.